Company: RGBP
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001641172-25-011206
Chunk: 15

Company: Regen BioPharma Inc
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
 such distributions may be made in cash or in property taken
at its fair value (as determined in good faith by the Board), or both, at the election of the Board.

On January 10, 2017 Regen Biopharma, Inc. (“ Regen”)
filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary of State setting forth the preferences
rights and limitations of a newly authorized series of preferred stock designated and known as “ Series M Preferred Stock”
(hereinafter referred to as “ Series M Preferred Stock”).

The Board of Directors of Regen have authorized60,000,000shares of the Series M Preferred Stock, par value $0.0001. With respect to each matter submitted to a vote of stockholders of Regen, each
holder of Series M Preferred Stock shall be entitled to cast that number of votes which is equivalent to the number of shares of Series
M Preferred Stock owned by such holder times one. Except as otherwise required by law holders of Common Stock, other series of Preferred
issued by Regen, and Series M Preferred Stock shall vote as a single class on all matters submitted to the stockholders.

The holders of Series M Preferred Stock shall be entitled
receive dividends, when, as and if declared by the Board of Directors in accordance with Nevada Law, in its discretion, from funds legally
available therefore

On any voluntary or involuntary liquidation, dissolution
or winding up of Regen, the holders of the Series M Preferred Stock shall receive, out of assets legally available for distribution to
Regen’s stockholders, a ratable share in the assets of Regen.

On March 26, 2021 Regen Biopharma, Inc. (“ Regen”)
filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary of State setting forth the preferences
rights and limitations of a newly authorized series of preferred stock designated and known as Nonconvertible Series NC Preferred Stock
(hereinafter referred to as “ Series NC Preferred Stock”).

The Board of Directors of Regen have authorized20,000shares of the Series NC Preferred Stock, par value $0.0001. With respect to each matter submitted to a vote of stockholders of Regen,
each holder of Series NC Preferred Stock shall be entitled to cast that number of votes which is equivalent to the number of shares of
Series NC Preferred Stock owned by such holder times 334. Except as otherwise required by law holders of Common